The Scientist

» human monoclonal antibodies

Most Recent

image: Dengue Antibodies Enhance Zika Infection?

Dengue Antibodies Enhance Zika Infection?

By | April 28, 2016

Previous flavivirus infection could help explain the severity of symptoms in some people infected during the ongoing Zika outbreak, researchers report.

1 Comment

image: Antibody Alternatives

Antibody Alternatives

By and | February 1, 2016

Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

2 Comments

image: Building Better Reagents

Building Better Reagents

By and | February 1, 2016

Facing problems of inconsistent, time-consuming, and costly antibody production, some researchers are turning to alternatives to target specific proteins of interest, in the lab and in the clinic.

0 Comments

image: Accelerating Antibody Discovery

Accelerating Antibody Discovery

By | May 1, 2014

Techniques for faster discovery and isolation of human monoclonal antibodies

0 Comments

image: Your Brain on Art

Your Brain on Art

By | May 1, 2014

A new scientific discipline investigates the neurology underlying the experience and the creation of beauty.

0 Comments

image: Toward Stopping MERS Spread

Toward Stopping MERS Spread

By | April 30, 2014

Independent teams culture the Middle East respiratory system coronavirus and identify human antibodies that could inform therapies.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham